Compare Gen Digital Inc. Common Stock (GEN) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gen Digital Inc. Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Gen Digital Inc. Common Stock trades at $23.2 (market cap $13.61B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: Gen Digital Inc. Common Stock and Halozyme Therapeutics Inc. Common Stock are close in size by market cap, and Gen Digital Inc. Common Stock pays a 2.2% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gen Digital Inc. Common Stock for 1 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| GEN | HALO | |
|---|---|---|
Market Cap | $13.61B | $12.58B |
Volume | 10,697,883 | 2,179,278 |
Sector | Technology | Health |
52-Week High | $31.41 | $115.22 |
52-Week Low | $17.89 | $61.63 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $21.25B | $14.49B |
Dividend Yield | 2.2% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gen Digital Inc. Common Stock
Gen Digital provides cybersecurity, online privacy, identity protection, and financial wellness services. Its consumer brands include Norton, Avast, LifeLock, and MoneyLion.
Read more on GEN →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
